We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

HospiMedica

Download Mobile App
Recent News AI Critical Care Surgical Techniques Patient Care Health IT Point of Care Business Focus

Surgical System with Miniaturized and Flexible Robotic Arms Could Be a Game-Changer for Endoluminal Surgery

By HospiMedica International staff writers
Posted on 20 Apr 2023

An innovative endoscopic surgical system, featuring highly miniaturized and flexible robotic arms, has the potential to revolutionize endoluminal surgery for both medical practitioners and patients.

The endoscopic surgery system from Agilis Robotics (Science Park, Hong Kong) boasts a unique combination of features that distinguish it from traditional surgical robotic systems. With its compact design and user-friendly interface, which requires minimal training, this cutting-edge surgical system is set to transform the realm of minimally invasive surgeries. One of the system's most notable attributes is its extraordinary flexibility. Offering five degrees of freedom per arm and a completely flexible body, it enables surgeons to perform intricate tissue resection procedures with remarkable precision and ease within natural orifices. This exceptional maneuverability, combined with its intuitive control interface and artificial intelligence support, is invaluable in endoscopic surgery, where skillful manipulation of surgical instruments is extremely difficult without robotic assistance.


Image: Live swine trial of the surgical robotic arms that can transform endoscopic surgery (Photo courtesy of Agilis)
Image: Live swine trial of the surgical robotic arms that can transform endoscopic surgery (Photo courtesy of Agilis)

Agilis recently demonstrated the system's capabilities in a trial using a live pig subject, successfully performing endoscopic submucosal dissection (ESD) in the upper and lower gastrointestinal tract with the robotic system. Additionally, an endoscopic ex-vivo trial on tracheal tissue was conducted, in which tissue from the trachea was successfully dissected, further showcasing the system's versatility and adaptability across various surgical scenarios.With these encouraging results, Agilis is now targeting FDA 510(k) clearance by 2025. This clearance would enable the company to market its robotic system and make a significant impact in the field of endoscopic surgery.

Related Links:
Agilis Robotics 


Gold Member
STI Test
Vivalytic Sexually Transmitted Infection (STI) Array
Gold Member
12-Channel ECG
CM1200B
Silver Member
Wireless Mobile ECG Recorder
NR-1207-3/NR-1207-E
New
Enterprise Imaging & Reporting Solution
Syngo Carbon

Latest Surgical Techniques News

World’s Smallest Laser Probe for Brain Procedures Facilitates Ablation of Full Range of Targets

Artificial Intelligence Broadens Diagnostic Abilities of Conventional Coronary Angiography

AI-Powered Surgical Visualization Tool Supports Surgeons' Visual Recognition in Real Time